Skip to main content

Table 3 History of NP-C manifestations for all patients in the NPC Registry prior to enrollment

From: Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: a final report of the NPC Registry

Manifestation

N

Overall patients

n (%)

Neurological manifestations

 Ataxia

448

304 (67.9)

 Vertical supranuclear gaze palsy

448

302 (67.4)

 Dysarthria

448

290 (64.7)

 Cognitive impairment/learning difficulties/school failure

448

281 (62.7)

 Dysphagia

448

220 (49.1)

 Dystonia

448

180 (40.2)

 Seizures

448

115 (25.7)

 Clumsiness

448

92 (20.5)

 Cataplexy

448

87 (19.4)

 Behavioral disturbance

448

63 (14.1)

 Psychiatric manifestations

448

50 (11.2)

 Sleep disturbance

448

36 (8.0)

 Difficulties stepping down

448

31 (6.9)

 Horizontal gaze palsy

448

22 (4.9)

 Other

448

21 (4.7)

Visceral manifestations in infancy

 Splenomegaly

398

199 (50.0)

 Hepatomegaly

397

147 (37.0)

 Pulmonary infiltration

448

24 (5.4)

  1. N Number of enrolled patients with evaluable data